PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
- Type: Other
- Archiver: EGA European Genome-Phenome Archive
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001001391 | Illumina HiSeq 2000 | 3 |
| Publications | Citations |
|---|---|
|
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Oncotarget 6: 2015 36418-36425 |
14 |